4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer
Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells. It is not
yet known whether combination chemotherapy is more effective than observation alone in
treating bladder cancer.
PURPOSE: This randomized phase III trial is studying combination chemotherapy to see how well
it works compared to observation alone in treating patients with bladder cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Southwest Oncology Group
Collaborators:
National Cancer Institute (NCI) NCIC Clinical Trials Group University of Southern California